Peptides for Sexual Health and Fertility Research: Complete Guide (2026)

Peptides for Sexual Health and Fertility Research: Complete Guide (2026)

Sexual health and fertility are complex systems regulated by hormones, neuropeptides, and vascular signaling. Research peptides in this space span libido modulation (PT-141, Melanotan II), growth hormone-releasing peptides that support reproductive hormone balance, and peptides studied for erectile function and fertility. This comprehensive guide examines the most studied peptides for sexual health and fertility research: PT-141, Melanotan II, Kisspeptin-10, GHRPs, and others.

Related reading: For hormonal axis context, see our Growth Hormone-Releasing Peptides Guide and Peptides for Athletic Performance Guide.

The Peptide Biology of Sexual Health

Sexual function and fertility are regulated by multiple peptide systems:

• Hypothalamic-pituitary-gonadal (HPG) axis: GnRH (gonadotropin-releasing hormone) drives LH/FSH → gonadal steroid production and gametogenesis
• Melanocortin system: Melanocortin receptors (MC3/MC4) regulate sexual arousal and libido
• Kisspeptin system: Kisspeptin is a master regulator of GnRH neurons — central to puberty and fertility
• Oxytocin: Regulates bonding, orgasm, and sexual response
• Vasopressin: Affects sexual and social behavior
• Nitric oxide pathway: Central to erectile function (cGMP-mediated)
• Growth hormone/IGF-1: Supports reproductive tissue health and libido

PT-141 (Bremelanotide): The Libido and Arousal Peptide

PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist (MC3/MC4) developed from Melanotan II by removing the melanotropic (tanning) component. It is FDA-approved (as Vyleesi) for hypoactive sexual desire disorder (HSDD) in premenopausal women:

Mechanisms:

• Sexual arousal: Activates central melanocortin pathways (MC3/MC4 receptors in the hypothalamus) that regulate sexual arousal and desire
• Non-hormonal: Acts centrally on neural circuits — does not require testosterone or estrogen
• Works regardless of libido origin: Effective in models of both psychogenic and physiological arousal deficits
• Erectile function: Studied in men with erectile dysfunction (especially psychogenic ED) — works through central arousal mechanisms distinct from PDE5 inhibitors (Viagra)

Research findings:

• FDA-approved for HSDD in women (Vyleesi, 2020) — a landmark approval for sexual desire disorders
• Clinical trials: significant improvement in sexual desire and distress scores
• Men: studies show improvement in erectile function, particularly in psychogenic ED
• Onset: typically 15-45 minutes after injection; duration several hours

Research dosing: 0.75-1.75mg subcutaneous (as needed, up to once per 24h). Note: injection site reactions, nausea, flushing are common side effects.

Melanotan II: Arousal Plus Pigmentation

Melanotan II (MT-II) is the parent compound of PT-141 — a synthetic melanocortin agonist with both tanning (MC1) and arousal (MC3/MC4) effects:

Effects:

• Sexual arousal: Same MC3/MC4 mechanism as PT-141 — spontaneous erections and increased libido are well-known effects
• Tanning: MC1 receptor activation stimulates melanin production (eumelanin) — “the tanning peptide”
• Photoprotection: May provide some UV protection through melanin

Research considerations and risks:

• Melanoma risk concern: Melanocortin receptor activation raises questions about melanocyte proliferation — caution in individuals with melanoma risk/history, many moles, or family history
• Side effects: Nausea, facial flushing, appetite suppression, darkening of existing moles (must monitor moles)
• Non-selective: MT-II activates all melanocortin receptors — PT-141 is more selective for arousal

Research dosing: 0.25-1mg, 1-3 times weekly (tanning protocols); as-needed for arousal. Start low (tolerance builds).

Kisspeptin-10: The Fertility Master Regulator

Kisspeptin is a naturally occurring peptide that is the master regulator of the reproductive axis — it directly stimulates GnRH neurons:

Mechanisms:

• GnRH stimulation: Kisspeptin activates GnRH neurons → LH and FSH release → gonadal function
• Puberty initiation: Kisspeptin signaling is essential for puberty onset
• Fertility regulation: Kisspeptin neurons integrate metabolic, stress, and circadian signals to regulate fertility
• Reproductive recovery: Studied for restoring reproductive function in functional hypothalamic amenorrhea (FHA)

Research findings:

• Human studies: kisspeptin-10 administration stimulates LH/FSH release in healthy volunteers
• Clinical trials in women with FHA (hypothalamic amenorrhea): kisspeptin restores LH pulsatility and ovulation in some women
• IVF research: studied as an alternative trigger for oocyte maturation (replacing hCG in some protocols)
• Male fertility: stimulates the HPG axis — studied for hypogonadotropic hypogonadism
• Emerging: kisspeptin analogs for fertility treatment

Research dosing: 0.2-1.6 nmol/kg (approximately 0.2-1.6mcg/kg) as IV bolus or subcutaneous, in clinical research protocols. Human data is from clinical studies — not a “supplement.”

GHRPs and the Reproductive Axis (Ipamorelin, GHRP-2, GHRP-6)

Growth hormone-releasing peptides affect reproductive health indirectly through the GH/IGF-1 axis:

• Libido support: GH/IGF-1 support general vitality, body composition, and sexual function (especially in GH-deficient states)
• Testicular function: GH is permissive for testicular steroidogenesis
• Recovery: Improved body composition and energy support sexual health
• Note: GHRPs do NOT directly stimulate the HPG axis — effects are indirect and modest
• GHRP-2/6: Also have prolactin effects (can raise prolactin) — relevant for fertility research (elevated prolactin suppresses gonadal function)

Research dosing: Ipamorelin 200-300mcg, 1-2 times daily; see our CJC-1295 + Ipamorelin Guide.

Other Sex-Health-Relevant Peptides

Oxytocin: Enhances bonding, sexual arousal, orgasm intensity; studied for sexual dysfunction (especially psychogenic). Dosing: 10-50 IU intranasal, as needed.

Vasopressin (and analogs): Affects sexual behavior and bonding; research-stage for sexual function.

GnRH analogs (Goserelin, Leuprolide): Powerful reproductive axis regulators — used clinically to suppress (cancer, endometriosis) or stimulate (fertility protocols). Prescription-only; relevant context for understanding HPG modulation.

HCG (not a peptide but related): LH analog — supports testicular function and fertility; used in TRT adjunct protocols (hCG monotherapy for fertility preservation).

PT-141 vs. PDE5 inhibitors: PDE5 inhibitors (Viagra/Cialis) work on vascular relaxation; PT-141 works on central arousal — complementary mechanisms, sometimes combined in research settings (with caution).

Erectile Function Research: Peptide Approaches

• PT-141: Central arousal pathway — effective for psychogenic ED
• Oxytocin: Enhances sexual response and arousal
• Melanotan II: Central arousal (spontaneous erections)
• Nitric oxide-supporting peptides: Research-stage peptides supporting endothelial NO production
• Foundation: Cardiovascular health, sleep, testosterone optimization, stress management

Fertility Research: Peptide Approaches

• Kisspeptin-10: Master regulator — most promising fertility peptide (FHA, IVF)
• GnRH analogs: Clinical fertility protocols (controlled ovarian stimulation)
• HCG: Oocyte maturation trigger; male fertility support
• FSH/LH peptides: Direct gonadotropin support (clinical use in infertility)
• GHRPs: Indirect support through GH/IGF-1

Important Research Considerations

• Side effects: PT-141/MT-II — nausea, flushing, hypertension (monitor BP; caution in cardiovascular disease); MT-II — mole darkening (monitor), melanoma risk concern
• Interactions: Avoid combining melanocortin peptides with MAO inhibitors or other serotonergic agents (hypertensive risk); caution with cardiovascular medications
• Fertility complexity: Fertility involves multiple axes — peptide approaches should be guided by clinical evaluation (hormone panels, semen analysis, imaging)
• Quality sourcing: COA-verified purity (≥98%), endotoxin testing, correct peptide identification (PT-141 vs MT-II confusion is dangerous — they differ in pigmentation effects). See our Purity Testing Guide.

Evidence Grading

Peptide	Sexual health evidence	Status
PT-141 (Bremelanotide)	Strong clinical (HSDD, ED)	FDA-approved (Vyleesi)
Kisspeptin-10	Moderate-Strong (fertility, HPG)	Clinical research
Melanotan II	Moderate (arousal); tanning	Research (risk concerns)
Oxytocin	Moderate (bonding, arousal)	Research
GHRPs	Indirect (vitality, body comp)	Research

Conclusion

For sexual health research, PT-141 offers the strongest clinical evidence for desire and arousal disorders, while kisspeptin-10 is the most promising peptide for fertility research. Melanotan II provides arousal effects alongside pigmentation but carries melanoma risk considerations. As always, sexual and reproductive health are multifactorial — hormone balance, cardiovascular health, sleep, and psychological factors matter enormously. Research peptides should be used with quality sourcing, appropriate monitoring, and honest expectations.

More resources:

• Peptides for Cardiovascular Health Guide
• Growth Hormone-Releasing Peptides Guide
• Peptides for Sleep and Recovery Guide
• Peptide FAQ: 50 Most Common Questions Answered

Shop high-quality research peptides: Visit Hanpro Peptides shop for 60+ high-purity research peptides with third-party COA verification.

For research use only. Not for human consumption. This information is for educational and research purposes only and does not constitute medical advice. Always follow institutional guidelines and applicable regulations for handling research compounds. Consult a qualified healthcare provider for medical advice or treatment.